Renal Cancer News
The daily renal cancer news is a unique cancer news service that evaluates all aspects of renal cancer research and reports on the developments that are most important to cancer patients and health care providers. The daily cancer news provides information about emerging options for renal cancer prevention, early detection and renal cancer treatment, as well as advances in supportive care and personalized medicine. Supportive care improves quality of life by making renal cancer treatment more tolerable, and personalized medicine offers the potential for improved treatment outcomes by using specific characteristics of the patient or the cancer to guide cancer treatment decisions. In addition, interested individuals can search the Cancer Consultants Renal Cancer News Archives to find the results of the cancer studies that led to the care they have been offered.
Renal Cancer News
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading
Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National... Continue Reading
The results from three phase III trials shed new light on treatment options for patients with advanced renal cell carcinoma. The studies were presented at the ESMO 2012 Congress of the European Society... Continue Reading
The investigational drug BMS-936558 caused tumor shrinkage in nearly 25 percent of patients with advanced melanoma, kidney cancer and non-small cell lung cancer (NSCLC), according to the results of a phase... Continue Reading
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according... Continue Reading
Patients with early stage kidney cancer who had only the tumor removed experienced better survival rates than those who had the entire kidney removed, according to the results of a study published in the... Continue Reading
Tivozanib (AV-951) was well tolerated and improved median progression-free survival (PFS) in some patients with advanced renal cell carcinoma (RCC), according to the results of a phase II study published... Continue Reading
A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading
Some patients with metastatic kidney cancer experience a complete response (a complete disappearance of detectable cancer) after treatment with Sutent® (sunitinib) or Nexavar® (sorafenib), but researchers... Continue Reading
A study of families with Lynch Syndrome has expanded the list of cancers related to the condition: carriers of a Lynch Syndrome gene mutation also appear to have an increased risk of breast cancer and... Continue Reading
Latest Renal Cancer News By Stage
General
New Treatment Options for Advanced Renal Cell Carcinoma (October 8, 2012)
The results from three phase III trials shed new light on treatment options for patients with advanced renal cell carcinoma. The studies were presented at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. More than 58,000... Continue Reading
PD-1 Targeted Immune Therapy Shows Promising Activity (June 11, 2012)The investigational drug BMS-936558 caused tumor shrinkage in nearly 25 percent of patients with advanced melanoma, kidney cancer and non-small cell lung cancer (NSCLC), according to the results of a phase I study presented at the 2012 annual meeting... Continue Reading
Partial Nephrectomy is Associated with Improved Survival in Early Stage Kidney Cancer (April 27, 2012)Patients with early stage kidney cancer who had only the tumor removed experienced better survival rates than those who had the entire kidney removed, according to the results of a study published in the Journal of the American Medical Association.[1] Nearly... Continue Reading
Tivozanib Promising for Metastatic Renal Cell Carcinoma (April 23, 2012)Tivozanib (AV-951) was well tolerated and improved median progression-free survival (PFS) in some patients with advanced renal cell carcinoma (RCC), according to the results of a phase II study published in the Journal of Clinical Oncology. More than... Continue Reading
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading
More General
